openPR Logo
Press release

Fibromyalgia Treatments (FM) Market 2018; Expand At 17.5% CAGR | the Anti-Seizure Drugs Segment Holds the Largest Share in the FM Market by 2023 – Avail At MRFR

06-20-2018 12:20 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Fibromyalgia Treatments Market

Fibromyalgia Treatments Market

Fibromyalgia Treatments Market   - Overview

Fibromyalgia (FM) conditions arise due to the accidental impact, lasting excruciated muscle pain and fatigue. Although there is no cure for FM, treating its symptoms can make the condition manageable. It is treated by prescribing antidepressants to reduce pain and improve sleep. Simultaneously, other treatments such as counseling, CBT (cognitive behavior therapy) exercises and relaxation techniques are suggested to benefit in reducing pain and muscles tension.

Cases of road accidents have been rising at an alarming rate, leading to increasing the prevalence of fibromyalgia and hence the demand for effective treatments of FM. Simultaneously, prevailing psychiatric disorders and post-traumatic stress disorders also act as risk factors, increasing the fibromyalgia cases. Therefore, the Fibromyalgia Treatments market is growing pervasively on the global platform.

Get Exclusive Sample Copy of Fibromyalgia Treatments Market spread across 85 Premium Pages, 10+ Companies and Full TOC is Available @ https://www.marketresearchfuture.com/sample_request/1879 .

Acknowledging the exponential growth the market perceives currently; Market Research Future (MRFR), in its recently published market forecast asserts that the global Fibromyalgia Treatment market will grow exponentially by 2023, registering a striking CAGR of 17.5% throughout the forecast period (2017 – 2023).

The technological advancements transpired in the field of medical science are offering extraordinary relief and benefitting results, proving to be a boon to the patients, improving their quality of life. Thus, provide impetus to the market growth of Fibromyalgia Treatments.   Other factors fostering the market growth include increasing cases of rheumatic diseases and growing awareness among the patients towards the availability of effective treatments for FM. Rising geriatric population, coupled with the unmet medical needs are fostering the market growth of fibromyalgia treatments.

On the other hand, unmet medical needs due to the lack of infrastructure and technical competencies ending in complicating diagnosis processes are some of the key factor impeding the market growth especially in the middle- and low-income countries.  Nevertheless, developing technologies are likely to present new techniques to treat the condition, which will further increase the market growth during the assessment period.

Top Players:

Market players driving the Global Fibromyalgia Treatments Market include GlaxoSmithKline, Pfizer, AstraZeneca, Astellas Pharma, F. Hoffmann-La Roche AG, Johnson & Johnson Services, Inc., Eli Lilly and Company, SANOFI, ALLERGAN, Bayer AG, Boehringer Ingelheim, Cephalon, Inc., AbbVie, Sunovion Pharms, Inc., Vertical Pharmaceuticals, Abbott, Novartis, and Jazz Pharmaceuticals. Profiling them in its analysis MRFR finds the strategies helping them to stay at the forefront of competition.

Global Fibromyalgia Treatments Market   - Competitive Landscape

The competitive market for Fibromyalgia Treatments is fragmented with many large and small players operating in the market. Market players incorporate acquisition, collaboration, expansion, technology launch and strategic partnership. These players substantially invest in R&D and clinical trials to develop effective drugs.

To help accelerate pharmaceutical innovations and to gain a better understanding of the conditions, these pharma companies collaborate with academia and the biotech industry partners who can contribute cutting-edge technologies and specialized knowledge.

These collaborations are one of the innovation strategies of market players. Companies can leverage the latest scientific knowledge and translate it into innovative medicines through partnering. These partnerships can kindle the innovative impulses that advance medicine and benefit patients as well as partners.

Ask any Queries to Experts about Niche Segments, Requires Regional Data and Top Players @ https://www.marketresearchfuture.com/enquiry/1879 .

Industry/Innovation/ Related News:

April 18, 2018 – Quell/NeuroMetrix Inc., (US), a company involved in patented diagnostic technology and innovative wearable therapy solutions to ease the chronic pain and sleep disorders announced that its wearable device is proving to be a practical approach to help reduce chronic pain effectively, easing chronic pain in patients suffering from fibromyalgia by interfering with activity and mood.

Fibromyalgia Treatments Market      - Segmentations

MRFR has segmented the report into three key dynamics for an easy grasp and enhanced understanding:-

By Treatments: Comprises - Targeted (Anti-depressant & Anti-Seizure Drug), and Symptomatic Treatment among others. 

By Diagnosis: Laboratory Evaluation and Presence of Central Sensitization among others.

By End Users: Hospitals & Clinics, Research Centers, and Laboratories among others.

By Regions: North America, Europe, APAC and Rest of the World.

Global Fibromyalgia Treatments Market      - Regional Analysis

Globally North America leads the Fibromyalgia Treatments market with the significant market share. The Market is expected to grow phenomenally during 2017 to 2023. Attributing to the favorable reimbursement scenario and greater expenditure on healthcare the market is expected to perceive a healthy growth. Another important driver for the regional market growth is the rapid uptake of new technologies in the US. Furthermore, rising cases of chronic rheumatic diseases coupled with the rising awareness among people foster the market growth in the region.

Europe emerging as a lucrative Fibromyalgia Treatments market will grow at a phenomenal CAGR.  The resurging economy in the region is expected to foster the regional market growth, increasing per capita healthcare expenditures. The financial support provided by private and governments bodies for R&D activities and new improved reimbursement policies in healthcare will fuel the Fibromyalgia Treatment market in Europe.

Asia Pacific market for the Fibromyalgia Treatments is expected to perceive the fastest growth by 2023 at a modest CAGR during 2017 to 2023. India and China backed by the huge population and the availability of low-cost drugs for the treatment will lead the market growth.

Moreover, the rapidly growing healthcare sector coupled with the large unmet needs over the forecast period will provide impetus to the market growth. Vietnam, Thailand, and Malaysia among other South East Asian countries are projected to contribute significantly to the regional market growth. Besides the growing penetration of healthcare insurance is expected to drive the Fibromyalgia Treatments market in the in the Asia Pacific region.

Avail Stunning Discount @ https://www.marketresearchfuture.com/check-discount/1879 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia Treatments (FM) Market 2018; Expand At 17.5% CAGR | the Anti-Seizure Drugs Segment Holds the Largest Share in the FM Market by 2023 – Avail At MRFR here

News-ID: 1090219 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Treatment

Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value. View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products. Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview: The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025. Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any
Health Tourism Market Global Industry Analysis, By Key Players, Segmentation, Tr …
Huge increase in demand and new phenomenon in the healthcare industry known as health tourism. It is one of the fastest growing industry and economic growth areas globally, as people today demanding for better quality, faster and cheaper alternatives of healthcare offered in their own countries. Health tourism is also known as medical travel or global health care, defined as the act of travelling to foreign countries with purpose of
Addiction Treatment Market: Tobacco/Nicotine Addiction Treatment Dominates the M …
Transparency Market Research (TMR) has published a new report titled “Addiction Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2017–2025”. According to the report, the global addiction treatment market was valued at approximately US$ 4.0 Bn in 2016 is projected to expand at a CAGR of over 6.0% from 2017 to 2025. The report suggests that growing abuse of prescription drugs and favorable reimbursements for smoking